Currently, there are 1.92B common shares owned by the public and among those 1.92B shares have been available to trade.
The company’s stock has a 5-day price change of 1.57% and 1.14% over the past three months. KVUE shares are trading 11.80% year to date (YTD), with the 12-month market performance up to 24.00% higher. It has a 12-month low price of $17.67 and touched a high of $25.17 over the same period. KVUE has an average intraday trading volume of 17.41 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.29%, 2.32%, and 5.57% respectively.
Institutional ownership of Kenvue Inc (NYSE: KVUE) shares accounts for 100.55% of the company’s 1.92B shares outstanding.
It has a market capitalization of $45.83B and a beta (3y monthly) value of 0.91. The stock’s trailing 12-month PE ratio is 43.53, while the earnings-per-share (ttm) stands at $0.55. The company has a PEG of 9.55 and a Quick Ratio of 0.60 with the debt-to-equity ratio at 0.88. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.25% over the week and 1.70% over the month.
Analysts forecast that Kenvue Inc (KVUE) will achieve an EPS of 0.28 for the current quarter, 0.32 for the next quarter and 1.22 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.26 while analysts give the company a high EPS estimate of 0.26. Comparatively, EPS for the current quarter was 0.32 a year ago. Earnings per share for the fiscal year are expected to increase by 0.02%, and 7.21% over the next financial year. EPS should grow at an annualized rate of 4.56% over the next five years, compared to -6.66% over the past 5-year period.
Looking at the support for the KVUE, a number of firms have released research notes about the stock. Redburn Atlantic stated their Neutral rating for the stock in a research note on April 10, 2025, with the firm’s price target at $23.50. Evercore ISI coverage for the Kenvue Inc (KVUE) stock in a research note released on March 24, 2025 offered a In-line rating with a price target of $25. Piper Sandler was of a view on January 06, 2025 that the stock is Overweight, while Deutsche Bank gave the stock Hold rating on December 12, 2024, issuing a price target of $25- $24. Jefferies on their part issued Buy rating on September 24, 2024.
